| HTSCX | VSIIX | HTSCX / VSIIX | |
| Total Expense Ratio | 2.06 | 0.05 | 4,120% |
| Annual Report Gross Expense Ratio | 2.10 | 0.05 | 4,200% |
| Fund Existence | 22 years | 27 years | - |
| Gain YTD | 21.264 | 14.485 | 147% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 288M | 67.8B | 0% |
| Annual Yield % from dividends | 0.13 | 1.78 | 7% |
| Returns for 1 year | 18.49 | 20.77 | 89% |
| Returns for 3 years | 33.88 | 45.87 | 74% |
| Returns for 5 years | 7.52 | 45.96 | 16% |
| Returns for 10 years | 14.89 | 132.04 | 11% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OPER | 100.21 | 0.01 | +0.01% |
| ClearShares Ultra-Short Maturity ETF | |||
| SNPD | 29.96 | N/A | N/A |
| Xtrackers S&P Div Arstcrts Scrn ETF | |||
| BME | 42.95 | -0.06 | -0.14% |
| Blackrock Health Sciences Trust | |||
| JFLX | 50.03 | -0.11 | -0.22% |
| JPMorgan Flexible Debt ETF | |||
| VLUE | 193.78 | -1.59 | -0.81% |
| iShares MSCI USA Value Factor ETF | |||